Labs / ADME, DMPK & toxicology
Accutar Biotech
Cranbury, NJ, United States · accutarbio.com
Accutar Biotech is a U.S.-based company in Cranbury, New Jersey that applies artificial intelligence to drug discovery. It works through a hybrid approach that combines computational drug design with wet lab validation to support preclinical drug discovery efforts and pipeline development.
They take quote requests by email.
What they offer
Target discovery
Uses pan target cross-dock methods for target discovery in preclinical drug discovery workflows.
Hit identification
Uses virtual screening to identify hits, in place of high-throughput screening or other screening formats.
Hit validation
Uses docking to support hit validation by co-crystallization and binding assays.
Lead identification and optimization
Supports lead identification and lead optimization through clinical lead selection workflows.
Medicinal chemistry optimization
Supports optimization for potency, ADME, and toxicology.
ChemiRise
A data-driven retrosynthesis engine.
Orbital
A deep neural net based docking platform.
Virtual Screen
Fast and accurate virtual screening of over 10 million compounds.
Intelligent-SAR
An automatic and intelligent lead optimization platform.
Chemi-Net
A data-driven method for ADME property prediction.
What they work on
- Modalities
- Small molecule, Antibody, ADC
- Assays and studies
- co-crystallization, binding assays, high throughput screen, virtual screening, ADME property prediction
- Scale and capacity
- over 10 million compounds
- Therapeutic areas
- metastatic castration-resistant prostate cancer (mCRPC)
- Sites
- Cranbury, United States
- Serves
- U.S., global
- Address
- 8 Clarke Drive Suite 4, Cranbury, NJ 08512
- Founded
- 2015
Similar labs. Aurigene Pharmaceutical Services, Receptor, Sai Life, Altogen Labs
Found in a contract services directory. Listing built from accutarbio.com. Work here? Claim this listing.